STRO Sutro Biopharma, Inc.

Fundamentals / CIK 0001382101 / USD

Sutro Biopharma, Inc. reported $45.11M in revenue and a net loss of $155.3M for the trailing twelve months ended September 30, 2026 (down 6.1% year over year), with a -265.0% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open STRO in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$175.5M$87.77M$0-$225.7MFY 2016 Revenue: $59.73MFY 2016 Net Income: $1.70M2016FY 2017 Revenue: $51.74MFY 2017 Net Income: -$19.69M2017FY 2018 Revenue: $38.42MFY 2018 Net Income: -$35.32M2018FY 2019 Revenue: $42.74MFY 2019 Net Income: -$119.2M2019FY 2020 Revenue: $42.72MFY 2020 Net Income: -$32.13M2020FY 2021 Revenue: $61.88MFY 2021 Net Income: -$105.5M2021FY 2022 Revenue: $67.77MFY 2022 Net Income: -$119.2M2022FY 2023 Revenue: $153.7MFY 2023 Net Income: -$106.8M2023FY 2024 Revenue: $62.04MFY 2024 Net Income: -$227.5M2024FY 2025 Revenue: $102.5MFY 2025 Net Income: -$191.1M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $102.5M $62.04M $153.7M $67.77M $61.88M $42.72M $42.74M $38.42M $51.74M $59.73M
Research & Development $166.4M $252.0M $180.4M $137.2M $104.4M $76.96M $65.61M $54.26M $54.64M $43.55M
Total Operating Expenses $260.9M $300.5M $243.0M $196.7M $160.4M $113.8M $98.20M $75.64M $71.01M $58.37M
Operating Income -$158.4M -$238.5M -$89.28M -$128.9M -$98.52M -$71.06M -$55.47M -$37.22M -$19.27M $1.36M
EBITDA -$151.0M -$231.2M -$82.46M -$123.3M -$93.68M -$66.76M -$50.69M -$32.68M -$14.28M $7.03M
Interest Expense -- -- $1.30M $2.40M $2.60M $2.30M $1.10M $1.62M $612K $0
Income Before Tax -$191.2M -$225.1M -$88.60M -$116.7M -$105.5M -$32.02M -- -- -- --
Income Tax Expense -$93K $2.36M $18.19M $2.50M $0 $103K $0 $0 $0 --
Net Income -$191.1M -$227.5M -$106.8M -$119.2M -$105.5M -$32.13M -$119.2M -$35.32M -$19.69M $1.70M
Basic EPS -$22.49 -$29.40 -$17.80 -$23.50 -$22.90 -$9.90 -$24.30 -$61.30 -$439.50 $0.00
Diluted EPS -$22.49 -$29.40 -$17.80 -$23.50 -$22.90 -$9.90 -$24.30 -$61.30 -$439.50 $0.00
Basic Shares Outstanding 8.5M 7.7M 6.0M 5.1M 4.6M 3.3M 2.3M 575.9K 44.8K 40.8K
Diluted Shares Outstanding 8.5M 7.7M 6.0M 5.1M 4.6M 3.3M 2.3M 575.9K 44.8K 40.8K

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Revenue $9.10M $9.84M $14.52M $11.65M $9.69M $63.74M $17.40M $14.81M
Research & Development $23.50M $31.70M $36.55M $36.64M $39.85M $38.33M $51.60M $71.04M
Total Operating Expenses $31.05M $39.73M $44.18M $49.70M $58.15M $67.09M $85.91M $80.07M
Operating Income -$21.96M -$29.89M -$29.66M -$38.05M -$48.46M -$3.35M -$68.51M -$65.26M
EBITDA -$20.71M -$28.63M -$28.38M -$36.42M -$46.56M -$1.45M -$66.61M -$63.39M
Income Before Tax -$31.49M -$38.53M -$38.50M -$46.84M -$56.86M -$11.52M -$75.96M -$70.09M
Income Tax Expense $0 $1.0K -$15K -$82K $0 -$18K $7.0K --
Net Income -$31.49M -$38.53M -$38.48M -$46.76M -$56.86M -$11.50M -$75.97M -$72.44M
Basic EPS -$1.90 -$2.33 -$2.94 -- -$6.66 -$1.35 -$9.08 --
Diluted EPS -$1.90 -$2.33 -$2.94 -- -$6.66 -$1.35 -$9.08 --
Basic Shares Outstanding 16.6M 16.6M 13.1M -- 8.5M 8.5M 8.4M --
Diluted Shares Outstanding 16.6M 16.6M 13.1M -- 8.5M 8.5M 8.4M --

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $58.13M $190.3M $69.27M $47.25M $30.41M $206.2M $4.96M $125.3M $22.02M
Short-Term Investments $83.30M $126.6M $264.4M $255.1M $130.3M $120.3M $112.9M $79.19M --
Cash & Short-Term Investments $141.4M $316.9M $333.7M $302.3M $160.8M $326.5M $117.9M $204.5M $22.02M
Accounts Receivable, Net $3.98M $8.62M $36.08M $7.12M $12.45M $5.56M $6.30M $2.49M $1.62M
Total Current Assets $150.9M $343.3M $421.5M $353.2M $218.5M $378.2M $128.6M $209.9M $25.63M
Property, Plant & Equipment, Net $10.65M $18.19M $21.94M $24.62M $22.55M $12.94M $9.63M $10.93M $14.00M
Long-Term Investments $0 $0 $0 $0 $68.78M $0 $15.61M $0 --
Other Non-Current Assets $495K $7.17M $3.57M $1.85M $1.66M $2.12M $2.54M $2.24M $1.13M
Total Non-Current Assets $22.90M $43.90M $49.19M $53.79M $122.9M $15.93M $27.80M $13.19M $15.14M
Total Assets $173.8M $387.2M $470.7M $406.9M $341.4M $394.1M $156.4M $223.1M $40.77M
Accounts Payable $7.57M $10.47M $9.44M $4.80M $6.01M $5.54M $5.58M $3.06M $2.90M
Short-Term Debt -- -- $4.06M $12.50M $9.38M -- $1.00M $4.72M $14.56M
Deferred Revenue (Current) $10.56M $69.78M $20.67M $16.76M $5.50M $14.60M $19.46M $21.57M $10.71M
Other Current Liabilities $2.91M $4.01M $3.90M $3.08M $2.75M $627K $901K $847K $143K
Total Current Liabilities $75.13M $131.9M $93.75M $66.55M $41.74M $29.60M $32.97M $36.42M $31.96M
Long-Term Debt -- -- $0 $3.77M $15.74M $24.55M $8.88M $10.00M --
Deferred Revenue (Non-Current) $2.03M $12.54M $53.38M $89.89M -- $6.10M $16.20M $44.60M $13.16M
Other Non-Current Liabilities $1.69M $1.69M $1.69M $119K $146K $481K $134K $102K $14K
Total Non-Current Liabilities $231.1M $210.7M $227.3M $123.3M $47.11M $32.47M $25.61M $55.18M $15.31M
Total Liabilities $306.3M $342.6M $321.1M $189.9M $88.84M $62.06M $58.58M $91.60M $47.27M
Total Debt (incl. Leases) $15.67M $23.15M $33.63M $50.43M $57.37M $24.55M $9.88M $14.72M $14.56M
Common Stock $9.0K $8.0K $61K $58K $46K $46K $23K $23K --
Retained Earnings -$978.0M -$786.9M -$559.4M -$452.6M -$333.4M -$227.9M -$195.7M -$150.3M -$115.0M
Accumulated Other Comp. Income $19K $39K $21K -$618K -$314K $129K $165K -$47K --
Total Stockholders' Equity -$132.5M $44.60M $149.6M $217.0M $252.6M $332.0M $97.79M $131.5M -$109.0M
Total Equity -$132.5M $44.60M $149.6M $217.0M $252.6M $332.0M $97.79M $131.5M -$109.0M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Cash & Cash Equivalents $46.85M $54.34M $73.68M $58.13M $65.93M $64.03M $106.2M $190.3M
Short-Term Investments $95.33M $110.0M $128.9M $83.30M $101.7M $141.1M $142.7M $126.6M
Cash & Short-Term Investments $142.2M $164.3M $202.6M $141.4M $167.6M $205.1M $249.0M $316.9M
Accounts Receivable, Net $12.81M $5.80M $12.48M $3.98M $3.92M $8.00M $13.56M $8.62M
Total Current Assets $159.5M $175.6M $221.0M $150.9M $182.1M $231.6M $287.4M $343.3M
Property, Plant & Equipment, Net $7.13M $8.36M $9.36M $10.65M $13.35M $14.98M $16.80M $18.19M
Long-Term Investments $0 $0 $0 $0 $0 $0 $0 $0
Other Non-Current Assets $1.98M $1.13M $1.09M $495K $0 $50K $85K $7.17M
Total Non-Current Assets $17.15M $18.82M $21.02M $22.90M $27.55M $30.73M $34.02M $43.90M
Total Assets $176.6M $194.5M $242.0M $173.8M $209.7M $262.4M $321.4M $387.2M
Accounts Payable $2.84M $3.36M $5.49M $7.57M $7.03M $4.31M $8.18M $10.47M
Deferred Revenue (Current) $8.27M $6.46M $9.40M $10.56M $8.98M $11.96M $68.98M $69.78M
Other Current Liabilities $2.64M $2.73M $3.03M $2.91M $15.79M $17.83M $14.17M $4.01M
Total Current Liabilities $54.31M $52.90M $70.81M $75.13M $71.89M $74.25M $133.0M $131.9M
Deferred Revenue (Non-Current) $1.78M $0 $1.23M $2.03M $3.76M $6.91M $8.57M $12.54M
Other Non-Current Liabilities $1.69M $1.69M $1.69M $1.69M $1.69M $1.69M $1.69M $1.69M
Total Non-Current Liabilities $254.9M $244.9M $238.1M $231.1M $225.0M $220.2M $214.2M $210.7M
Total Liabilities $309.2M $297.8M $308.9M $306.3M $296.9M $294.5M $347.2M $342.6M
Total Debt (incl. Leases) $9.70M $10.78M $13.63M $15.67M $17.66M $19.59M $21.40M $23.15M
Common Stock $17K $17K $17K $9.0K $85K $85K $84K $8.0K
Retained Earnings -$1.09B -$1.05B -$1.02B -$978.0M -$931.2M -$874.3M -$862.8M -$786.9M
Accumulated Other Comp. Income -$77K -$58K -$101K $19K $33K -$13K -$9.0K $39K
Total Stockholders' Equity -$132.5M -$103.3M -$66.89M -$132.5M -$87.27M -$32.11M -$25.81M $44.60M
Total Equity -$132.5M -$103.3M -$66.89M -$132.5M -$87.27M -$32.11M -$25.81M $44.60M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income -$191.1M -$227.5M -$106.8M -$119.2M -$105.5M -$32.13M -$55.74M -$35.32M -$19.69M $1.70M
Depreciation & Amortization $7.32M $7.22M $6.82M $5.69M $4.84M $4.30M $4.78M $4.54M $4.99M $5.66M
Stock-Based Compensation $14.01M $24.69M $24.91M $26.30M $23.24M $11.92M $10.31M $2.87M $1.39M $968K
Change in Receivables $4.64M $27.46M -$28.96M $5.34M -$6.89M $739K -$3.81M -$865K -$1.05M -$171K
Change in Payables -$2.47M $706K $4.81M -$1.23M $2.71M -$1.14M $2.25M $209K -$473K $874K
Operating Cash Flow -$177.2M -$191.5M -$111.6M $3.55M -$81.68M -$67.80M -$65.02M $12.68M -$37.07M -$13.15M
Capital Expenditure -- -- -- -- -- -- -- -$1.56M -$3.32M -$4.39M
Free Cash Flow -- -- -- -- -- -- -- $11.13M -$40.39M -$17.55M
Purchases of Investments -$264.9M -$461.5M -$460.3M -$216.7M -$248.7M -$130.7M -$196.2M -$81.46M -$14.22M -$52.30M
Investing Cash Flow $45.01M $218.5M -$3.92M -$35.02M -$97.31M $604K -$51.13M -$80.19M $32.60M $9.59M
Common Stock Issued $0 $25.00M $0 $0 -- $251.4M -$327K -- -- --
Share Repurchases -- -- -- -- -$7.0K -- -- -- -- --
Financing Cash Flow $44K $94.05M $137.6M $48.31M $3.26M $269.2M -$4.18M $170.8M $14.64M $177K
Net Change in Cash -$132.2M $121.0M $22.01M $16.84M -$175.7M $202.0M -$120.3M $103.3M $10.17M -$3.38M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Net Income -$31.49M -$38.53M -$38.48M -$46.76M -$56.86M -$11.50M -$75.97M -$72.44M
Depreciation & Amortization $1.24M $1.26M $1.28M $1.62M $1.90M $1.90M $1.90M $1.87M
Stock-Based Compensation $2.16M $2.01M $1.56M $1.66M $1.55M $5.26M $5.54M $5.92M
Change in Receivables -$7.02M $6.69M -$8.51M -$55K $4.08M $5.56M -$4.95M -$1.96M
Change in Payables -$491K -$1.69M -$2.55M $575K $2.68M -$3.85M -$1.88M $4.12M
Operating Cash Flow -$22.45M -$38.29M -$42.26M -$26.43M -$38.19M -$44.72M -$67.88M -$71.74M
Purchases of Investments -$32.26M -$27.85M -$124.7M -$4.04M -$89.94M -$28.59M -$142.4M -$126.0M
Investing Cash Flow $14.83M $19.36M -$45.26M $18.70M $39.99M $2.58M -$16.26M $87.49M
Financing Cash Flow $133K -$418K $103.1M -$64K $102K -$60K $66K -$24K
Net Change in Cash -$7.48M -$19.35M $15.55M -$7.80M $1.90M -$42.20M -$84.08M $15.73M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin -154.5% -384.3% -58.1% -190.3% -159.2% -166.3% -129.8% -96.9% -37.2% 2.3%
Net Profit Margin -186.5% -366.6% -69.5% -175.9% -170.6% -75.2% -278.9% -91.9% -38.1% 2.8%
Return on Equity (ROE) -- -510.0% -71.4% -54.9% -41.8% -9.7% -121.9% -26.8% -- --
Return on Assets (ROA) -109.9% -58.7% -22.7% -29.3% -30.9% -8.2% -76.2% -15.8% -48.3% --
Current Ratio 2.01x 2.60x 4.50x 5.31x 5.24x 12.78x 3.90x 5.76x 0.80x --
Quick Ratio 1.94x 2.47x 3.94x 4.65x 4.15x 11.22x 3.77x 5.68x 0.74x --
Debt to Equity -- 0.52x 0.22x 0.23x 0.23x 0.07x 0.10x 0.11x -- --
Revenue Growth (YoY) +65.2% -59.6% +126.8% +9.5% +44.8% 0.0% +11.2% -25.7% -13.4% --
Operating Income Growth (YoY) -- -- -- -- -- -- -- -- -1512.9% --
Net Income Growth (YoY) -- -- -- -- -- -- -- -- -1256.8% --
Operating Cash Flow Growth (YoY) -- -- -3245.0% -- -- -- -612.7% -- -- --
5Y Revenue / Share Growth -8.0% -56.9% -61.7% -98.8% -99.1% -- -- -- -- --
5Y Net Income / Share Growth -- -- -- -- -154.8% -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-09-30 2026-06-30 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31
Operating Margin -265.0% -319.6% -120.0% -154.5% -175.7% -196.3% -376.9% -384.3%
Net Profit Margin -344.2% -395.2% -154.2% -186.5% -205.2% -199.8% -369.1% -366.6%
Return on Equity (ROE) -- -- -- -- -- -- -- -510.0%
Return on Assets (ROA) -87.9% -92.9% -63.5% -109.9% -103.4% -79.5% -76.3% -58.7%
Current Ratio 2.94x 3.32x 3.12x 2.01x 2.53x 3.12x 2.16x 2.60x
Quick Ratio 2.85x 3.22x 3.04x 1.94x 2.39x 2.87x 1.97x 2.47x
Debt to Equity -- -- -- -- -- -- -- 0.52x
Revenue Growth (YoY) -6.1% -84.6% -16.5% -21.4% +13.8% +148.0% +33.8% -87.0%
Operating Income Growth (YoY) -- -- -- -- -- -- -- -251.2%
Net Income Growth (YoY) -- -- -- -- -- -- -- -333.2%
Operating Cash Flow Growth (YoY) -- -- -- -- -- -573.0% -- -609.8%
Source: SEC EDGAR CompanyFacts (CIK 0001382101) · from December 31, 2016 Data through September 30, 2026 · synced Nov 20, 2026, 05:46 UTC · Open in terminal